Skip to main content
SpringerLink
Log in

Imaging

PET–CT imaging in non-small-cell lung cancer

  • News & Views
  • Published:

From Nature Reviews Clinical Oncology

View current issue Sign up to alerts

Imaging is performed in patients with early stage non-small-cell lung cancer (NSCLC) for disease staging and to identify the patients most likely to benefit from surgery. Two recent randomized trials compared conventional staging plus PET with conventional staging alone in patients with NSCLC. Patients who underwent PET were more likely to avoid futile thoracic surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pieterman, R. M. et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N. Engl. J. Med. 343, 254–261 (2000).

    Article  CAS  PubMed  Google Scholar 

  2. Ung, Y. C. et al. Lung cancer disease site group of Cancer Care Ontario's program in evidence-based care. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. J. Natl Cancer Inst. 99, 1753–1767 (2007).

    Article  PubMed  Google Scholar 

  3. van Tinteren, H. et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359, 1388–1393 (2002).

    Article  PubMed  Google Scholar 

  4. Viney, R. C. et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J. Clin. Oncol. 22, 2357–2362 (2004).

    Article  PubMed  Google Scholar 

  5. Herder, G. J. et al. POORT Study Group. Traditional versus up-front 18F-fluorodeoxyglucose positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J. Clin. Oncol. 24, 1800–1806 (2006).

    Article  PubMed  Google Scholar 

  6. Fischer, B. et al. Preoperative staging of lung cancer with combined CT–PET. N. Engl. J. Med. 361, 32–39 (2009).

    Article  CAS  PubMed  Google Scholar 

  7. Maziak, D. E. et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann. Intern. Med. 151, 221–228 (2009).

    Article  PubMed  Google Scholar 

  8. Iglehart, J. K. Health insurers and medical imaging policy—a work in progress. N. Engl. J. Med. 360, 1030–1037 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Ratner, R. et al. (Eds) Institute of Medicine: Initial National Priorities for Comparative Effectiveness Research. (National Academies, Washington DC, 2009).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology McMaster University, Henderson Research Centre, Hamilton, ON, Canada

    Mark Levine

  2. Ontario Clinical Oncology Group, McMaster University, Henderson Research Centre, Hamilton, ON, Canada

    Jim Julian

Authors
  1. Mark Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jim Julian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Levine.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levine, M., Julian, J. PET–CT imaging in non-small-cell lung cancer. Nat Rev Clin Oncol 6, 619–620 (2009). https://doi.org/10.1038/nrclinonc.2009.163

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2009.163

  • Springer Nature Limited

This article is cited by

Search

Navigation